Crossmark

Determining the efficacy of functional liver imaging score (FLIS) obtained from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Albumin-Bilirubin (ALBI) grade and FLIS

Crossref DOI link: https://doi.org/10.1007/s00261-022-03557-7

Published Online: 2022-06-07

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aslan, Serdar https://orcid.org/0000-0003-2950-8767
Eryuruk, Uluhan https://orcid.org/0000-0001-6581-621X
Tasdemir, Merve Nur https://orcid.org/0000-0003-1028-8135
Cakir, Ismet Mirac https://orcid.org/0000-0002-4229-7493
License Information

Text and Data Mining valid from 2022-06-07

Version of Record valid from 2022-06-07
More Information

Article History

Received: 17 April 2022

Revised: 26 April 2022

Accepted: 13 May 2022

First Online: 7 June 2022

Declarations

:

: The authors declare that they have no conflict of interest.

: Due to its retrospective design, we waived the requirement for informed consent.

: Yes.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This prospective study was approved by Institutional Review Board.

: Written informed consent was obtained from all patients participating in the study.

Document is current

Any future updates will be listed below